☆ 4.6 Editorial Material

Challenges in estimating RSV-associated mortality rates

LANCET RESPIRATORY MEDICINE (2016)

期刊

LANCET RESPIRATORY MEDICINE

卷 4, 期 5, 页码 345-347

出版社

ELSEVIER SCI LTD

DOI: 10.1016/S2213-2600(16)30042-X

关键词

-

类别

Critical Care Medicine Respiratory System

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Geosciences, Multidisciplinary

Estimating Dissipation Rates Associated With Double Diffusion

L. Middleton, E. C. Fine, J. A. MacKinnon, M. H. Alford, J. R. Taylor

Summary: This study presents a new method for estimating kinetic energy dissipation rates forced by double-diffusive convection using temperature and salinity data. The method estimates the up-gradient diapycnal buoyancy flux associated with double diffusion. Experimental results show that the method maintains predictive skill in estimating dissipation rates.

GEOPHYSICAL RESEARCH LETTERS (2021)

添加到收藏夹

Review Immunology

Risk Factors for Poor Outcome or Death in Young Children With Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis

Ting Shi, Sophie Vennard, Sara Mahdy, Harish Nair

Summary: This study provides a comprehensive report on the association between various risk factors and poor outcome or death in young children with RSV-ALRTI. More research is needed to elucidate the risk factors associated with poor outcome or death using multivariable analysis.

JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018

Chelsea L. Hansen, Cecile Viboud, Sandra S. Chaves

Summary: This study analyzed death certificate data from 1999 to 2018 to understand the mortality burden associated with RSV and influenza. The findings showed that RSV and bronchiolitis deaths primarily occurred in children under 1 year old, while influenza deaths were more common in adults aged 65 and above. The study also found that infants were more likely to die outside of the hospital from respiratory pathogens compared to other causes, and race/ethnicity alone did not explain this disparity.

JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Immunology

Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis

John M. McLaughlin, Farid Khan, Heinz-Josef Schmitt, Yasmeen Agosti, Luis Jodar, Eric A. F. Simoes, David L. Swerdlow

Summary: Our systematic literature review and meta-analysis on RSV-associated hospitalization rates among US infants revealed an annual range from 8.4 to 40.8 per 1000, with a pooled rate of 19.4 per 1000. Study type significantly influenced the rates, with active surveillance studies showing lower rates (11.0) compared to studies using administrative claims (21.4) or modeling approaches (23.2).

JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Medicine, General & Internal

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

B. Kampmann, S. A. Madhi, I. Munjal, E. A. F. Simoes, B. A. Pahud, C. Llapur, J. Baker, G. Perez Marc, D. Radley, E. Shittu, J. Glanternik, H. Snaggs, J. Baber, P. Zachariah, S. L. Barnabas, M. Fausett, T. Adam, N. Perreras, M. A. Van Houten, A. Kantele, L. -M Huang, L. J. Bont, T. Otsuki, S. L. Vargas, J. Gullam, B. Tapiero, R. T. Stein, F. P. Polack, H. J. Zar, N. B. Staerke, M. Duron Padilla, P. C. Richmond, K. Koury, K. Schneider, E. V. Kalinina, D. Cooper, K. U. Jansen, A. S. Anderson, K. A. Swanson, W. C. Gruber, A. Gurtman

Summary: Vaccination of pregnant women with RSVpreF vaccine was effective in reducing severe RSV-associated lower respiratory tract illness in infants. The vaccine showed 81.8% efficacy within 90 days and 69.4% efficacy within 180 days. The vaccine was found to be safe for both mothers and infants.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses

Jimin Xu, Wenzhe Wu, Haiying Chen, Yu Xue, Xiaoyong Bao, Jia Zhou

Summary: The study identified a series of effective RSV inhibitors, including six low cytotoxic compounds, which not only suppressed viral replication but also inhibited specific signaling pathways induced by RSV, reducing the production of cytokines/chemokines. Two most potent compounds were selected for further molecular mechanism studies, showing their suppression effect on RSV-induced IRF3 and NF-kappa B signaling pathways.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Immunology

Association of Respiratory Syncytial Virus Infection and Underlying Risk Factors for Death Among Young Infants Who Died at University Teaching Hospital, Lusaka Zambia

Leah S. Forman, William Macleod, Lawrence Mwananyanda, Geoffrey Kwenda, Rachel Pieciak, Zachariah Mupila, Caitriona Murphy, Donald Thea, Chilufya Chikoti, Baron Yankonde, Benard Ngoma, Charles Chimoga, Christopher J. Gill

Summary: The study found a lack of association between RSV and underlying risk factors, except for congenital cardiac conditions. In the context of infant deaths in Zambia, birth-related outcomes were identified as the highest mortality risk factors.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Healthcare indicators associated with COVID-19 death rates in the European Union

C. Mattiuzzi, G. Lippi, B. M. Henry

Summary: The study found that in EU countries, the COVID-19 death rate was inversely associated with the number of available general hospitals, physicians, and nurses, and positively associated with acute care bed occupancy, population aged older than 65 years, overweight or cancer. However, total healthcare expenditure, public sector health expenditure, and the number of hospital and acute care beds did not influence COVID-19 death rate.

PUBLIC HEALTH (2021)

添加到收藏夹

Article Critical Care Medicine

Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children

Ruth A. Karron, Jessica E. Atwell, Elizabeth J. McFarland, Coleen K. Cunningham, Petronella Muresan, Charlotte Perlowski, Jennifer Libous, Stephen A. Spector, Ram Yogev, Mariam Aziz, Suzanne Woods, Kimberli Wanionek, Peter L. Collins, Ursula J. Buchholz

Summary: This study analyzed data from seven phase 1 trials of live-attenuated RSV vaccines and found that vaccine regimens that induced neutralizing antibody responses in >= 80% of vaccinees provided protection against RSV-associated diseases and primed for potent anamnestic responses upon natural exposure to wild-type RSV. Recipients of vaccines with a greater than or equal to fourfold increase in RSV serum neutralizing antibody following vaccination were strongly protected against RSV-MAARI and RSV-MAALRI.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Decomposition stages as a clue for estimating the post-mortem interval in carcasses and providing accurate bird collision rates

Virginia Moraleda, Julia Gomez-Catasus, Claudia Schuster, Luis M. Carrascal

Summary: The study evaluates factors influencing the decomposition stages of bird carcasses through two experiments and proposes an alternative protocol to estimate the post-mortem interval in wild birds.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Infectious Diseases

Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza

Alaa Atamna, Tanya Babich, Dafi Froimovici, Dafna Yahav, Nadav Sorek, Haim Ben-Zvi, Leonard Leibovici, Jihad Bishara, Tomer Avni

Summary: This study compared the clinical outcomes of patients with laboratory-confirmed RSV and patients with influenza infection, finding that RSV patients had higher rates of complications and were more prone to pneumonia. Hypoalbuminemia, reduced room-air saturation, and RSV infection were identified as predictors of complications.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Editorial Material Cell Biology

Fusing safety and efficacy: A maternal bivalent RSV prefusion F vaccine

Ann M. Miller, Steven M. Varga

Summary: In this phase 3 trial, Kampmann et al.1 demonstrated that a maternal bivalent RSV prefusion F vaccine is safe and effective. The vaccine effectively reduced the occurrence of severe RSV-associated lower respiratory tract infections in infants at 90 and 180 days following birth.

CELL REPORTS MEDICINE (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany

Christian Staerk, Tobias Wistuba, Andreas Mayr

Summary: This study investigates the time-dependent variations in effective IFR over the course of the COVID-19 pandemic in Germany using surveillance data and international studies. The results show that there are changes in the age distribution of infections, particularly during the first and second waves of infections in 2020, leading to fluctuations in effective IFR estimates.

BMC PUBLIC HEALTH (2021)

添加到收藏夹

Article Immunology

Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States

William L. Herring, Yuanhui Zhang, Vivek Shinde, Jeffrey Stoddard, Sandra E. Talbird, Brian Rosen

Summary: This study aimed to evaluate the potential clinical and economic benefits of RSV vaccination for older adults in the United States. The findings showed that vaccination could significantly reduce hospitalizations and deaths caused by RSV, as well as decrease the loss of quality-adjusted life-years and medical costs.

VACCINE (2022)

添加到收藏夹

Article Immunology

Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study

Stephen Mac, Scott Shi, Brad Millson, Ali Tehrani, Masha Eberg, Varun Myageri, Joanne M. Langley, Scott Simpson

Summary: This study investigated the incidence, healthcare resource use, and associated costs of adults hospitalized with RSV in Ontario, Canada. The findings revealed an increasing trend of RSV hospitalizations in adults, which were associated with higher healthcare costs.

VACCINE (2023)

添加到收藏夹

Article Obstetrics & Gynecology

Extended Perinatal Mortality Audit in a Rural Hospital in India

Nuria Torre Monmany, Joaquin Americo Astete, Dasarath Ramaiah, Jyothi Suchitra, Xavier Krauel, Manolo Fillol, Yadamala Balasubbaiah, Ana Alarcon, Quique Bassat

Summary: This study describes the status of perinatal mortality in an Indian rural hospital. The results show that antepartum complications are the main cause of perinatal deaths, while infections, congenital malformations, and prematurity are the main causes of neonatal deaths. The stillbirth rate is 11.8/1,000 births, neonatal mortality rate is 4.4/1,000 livebirths, and perinatal mortality rate is 15.8/1,000 births.

AMERICAN JOURNAL OF PERINATOLOGY (2023)

添加到收藏夹

Article Immunology

T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa

William C. McMahon, Gaurav Kwatra, Alane Izu, Anthonet L. Koen, Johann Greffrath, Lee Fairlie, Faeezah Patel, Christian K. Mukendi, Nkululeko J. Mbele, Rushil Lala, Wendy A. Burgers, Marta C. Nunes, Clare L. Cutland, Sarah C. Gilbert, Teresa Lambe, Andrew J. Pollard, Shabir A. Madhi

Summary: This study aimed to investigate the T-cell responses specific to SARS-CoV-2 in black Africans with and without HIV after receiving the AZD1222 vaccine. The study found that the T-cell responses were comparable between HIV-uninfected individuals and people living with HIV who were on stable antiretroviral therapy. In addition, individuals with prior SARS-CoV-2 infection showed a heightened T-cell response after receiving the AZD1222 vaccine.

AIDS (2023)

添加到收藏夹

Article Immunology

Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series

Yvette N. N. Lowensteyn, Joukje E. E. Willemsen, Natalie I. I. Mazur, Nienke M. M. Scheltema, Nynke C. J. van Haastregt, Amber A. A. ten Buuren, Ichelle van Roessel, Dunja Scheepmaker, Harish Nair, Peter M. M. van de Ven, Louis J. J. Bont

Summary: This study provides the first global case series of children dying with nosocomial RSV infection. Infant-targeted immunization strategies in the future could prevent the majority of nosocomial RSV-related deaths. Although nosocomial RSV deaths are expected to occur at highest rates in low- and lower-middle-income countries (LMICs), the reported number of these deaths was low in these countries. Hospital-based surveillance is needed to capture the full burden of nosocomial RSV mortality in LMICs.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

添加到收藏夹

Article Pediatrics

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Eric A. F. Simoes, Shabir A. Madhi, William J. Muller, Victoria Atanasova, Miroslava Bosheva, Fernando Cabanas, Manuel Baca Cots, Joseph B. Domachowske, Maria L. Garcia-Garcia, Ineta Grantina, Kim A. Nguyen, Heather J. Zar, Anna Berglind, Celeste Cummings, M. Pamela Griffin, Therese Takas, Yuan Yuan, Ulrika Waehlby Hamrin, Amanda Leach, Tonya Villafana

Summary: This study evaluated the efficacy of nirsevimab using a weight-banded dosing regimen in infants born between 29 weeks gestational age and full term. The results showed that a single dose of nirsevimab protected healthy infants born at term or preterm from RSV lower respiratory tract infection, reducing the incidence of hospital admissions and severe cases associated with RSV. Therefore, nirsevimab has the potential to alleviate the burden of infant RSV disease.

LANCET CHILD & ADOLESCENT HEALTH (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis

Emily R. Smith, Erin Oakley, Gargi Wable Grandner, Kacey Ferguson, Fouzia Farooq, Yalda Afshar, Mia Ahlberg, Homa Ahmadzia, Victor Akelo, Grace Aldrovandi, Beth A. Tippett Barr, Elisa Bevilacqua, Justin S. Brandt, Nathalie Broutet, Irene Fernandez Buhigas, Jorge Carrillo, Rebecca Clifton, Jeanne Conry, Erich Cosmi, Fatima Crispi, Francesca Crovetto, Camille Delgado-Lopez, Hema Divakar, Amanda J. Driscoll, Guillaume Favre, Valerie J. Flaherman, Chris Gale, Maria M. Gil, Sami L. Gottlieb, Eduard Gratacos, Olivia Hernandez, Stephanie Jones, Erkan Kalafat, Sammy Khagayi, Marian Knight, Karen Kotloff, Antonio Lanzone, Kirsty Le Doare, Christoph Lees, Ethan Litman, Erica M. Lokken, Valentina Laurita Longo, Shabir A. Madhi, Laura A. Magee, Raigam Jafet Martinez-Portilla, Elizabeth M. McClure, Tori D. Metz, Emily S. Miller, Deborah Money, Sakita Moungmaithong, Edward Mullins, Jean B. Nachega, Marta C. Nunes, Dickens Onyango, Alice Panchaud, Liona C. Poon, Daniel Raiten, Lesley Regan, Gordon Rukundo, Daljit Sahota, Allie Sakowicz, Jose Sanin-Blair, Jonas Soderling, Olof Stephansson, Marleen Temmerman, Anna Thorson, Jorge E. Tolosa, Julia Townson, Miguel Valencia-Prado, Silvia Visentin, Peter von Dadelszen, Kristina Adams Waldorf, Clare Whitehead, Murat Yassa, Jim M. Tielsch

Summary: Despite heterogeneity in study design and quality, a sequential, prospective meta-analysis found that SARS-CoV-2 infection during pregnancy increases the risk of maternal mortality, severe maternal morbidity, and neonatal morbidity. However, there is no association with stillbirth or intrauterine growth restriction. The findings highlight the importance of preventing and managing SARS-CoV-2 infection in pregnant women. Overall, the study is rated 8 out of 10 in terms of importance.

BMJ GLOBAL HEALTH (2023)

添加到收藏夹

Article Infectious Diseases

In-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) dataset

Shubhada Hooli, Carina King, Eric D. McCollum, Tim Colbourn, Norman Lufesi, Charles Mwansambo, Christopher J. Gregory, Somsak Thamthitiwat, Clare Cutland, Shabir Ahmed Madhi, Marta C. Nunes, Bradford D. Gessner, Tabish Hazir, Joseph L. Mathew, Emmanuel Addo-Yobo, Noel Chisaka, Mumtaz Hassan, Patricia L. Hibberd, Prakash Jeena, Juan M. Lozano, William B. MacLeod, Archana Patel, Donald M. Thea, Ngoc Tuong Vy Nguyen, Syed MA. Zaman, Raul O. Ruvinsky, Marilla Lucero, Cissy B. Kartasasmita, Claudia Turner, Rai Asghar, Salem Banajeh, Imran Iqbal, Irene Maulen-Radovan, Greta Mino-Leon, Samir K. Saha, Mathuram Santosham, Sunit Singhi, Shally Awasthi, Ashish Bavdekar, Monidarin Chou, Pagbajabyn Nymadawa, Jean-William Pape, Glaucia Paranhos-Baccala, Valentina Sanchez Picot, Mala Rakoto-Andrianarivelo, Vanessa Rouzier, Graciela Russomando, Mariam Sylla, Philippe Vanhems, Jianwei Wang, Sudha Basnet, Tor A. Strand, Mark I. Neuman, Luis Martinez Arroyo, Marcela Echavarria, Shinjini Bhatnagar, Nitya Wadhwa, Rakesh Lodha, Satinder Aneja, Angela Gentile, Mandeep Chadha, Siddhivinayak Hirv, Kerry-Ann F. O'Grady, Alexey W. Clara, Chris A. Rees, Harry Campbell, Harish Nair, Jennifer Falconer, Linda J. Williams, Margaret Horne, Shamim A. Qazi, Yasir Bin Nisar

Summary: This study found that pulse oximetry monitoring can reduce the mortality risk of pediatric pneumonia and identified risk factors for in-hospital mortality of chest-indrawing pneumonia. The conclusion is that pulse oximetry should be integrated into hospital care for pediatric pneumonia in children under 5 years.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

Editorial Material Infectious Diseases

Safety of COVID-19 booster dose: is the juice worth the squeeze?

Shabir A. Madhi, Alane Izu

LANCET INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Medicine, General & Internal

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

B. Kampmann, S. A. Madhi, I. Munjal, E. A. F. Simoes, B. A. Pahud, C. Llapur, J. Baker, G. Perez Marc, D. Radley, E. Shittu, J. Glanternik, H. Snaggs, J. Baber, P. Zachariah, S. L. Barnabas, M. Fausett, T. Adam, N. Perreras, M. A. Van Houten, A. Kantele, L. -M Huang, L. J. Bont, T. Otsuki, S. L. Vargas, J. Gullam, B. Tapiero, R. T. Stein, F. P. Polack, H. J. Zar, N. B. Staerke, M. Duron Padilla, P. C. Richmond, K. Koury, K. Schneider, E. V. Kalinina, D. Cooper, K. U. Jansen, A. S. Anderson, K. A. Swanson, W. C. Gruber, A. Gurtman

Summary: Vaccination of pregnant women with RSVpreF vaccine was effective in reducing severe RSV-associated lower respiratory tract illness in infants. The vaccine showed 81.8% efficacy within 90 days and 69.4% efficacy within 180 days. The vaccine was found to be safe for both mothers and infants.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Letter Medicine, General & Internal

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

William J. Muller, Shabir A. Madhi, Beatriz Seoane Nunez, Manuel Baca Cots, Miroslava Bosheva, Ron Dagan, Laura L. Hammitt, Conrado J. Llapur, Jose M. Novoa, Xavier Saez Llorens, Amy Grenham, Elizabeth J. Kelly, Vaishali S. Mankad, Manish Shroff, Therese Takas, Amanda Leach, Tonya Villafana

Summary: Nirsevimab, a monoclonal antibody, effectively prevents hospitalization and severe lower respiratory tract infection in term and late-preterm infants caused by respiratory syncytial virus (RSV).

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin

Andrea Alemany, Pere Millat-Martinez, Marc Corbacho-Monne, Clara Suner, Cristina Galvan-Casas, Caty Carrera, Dan Ouchi, Nuria Prat, Jordi Ara, Nuria Nadal, Ricard Riel, Blanca Funollet, Carmen Ojeda-Ciurana, Lluis Esteve Balague, Betlem Salvador-Gonzalez, Anna Forcada Arcarons, Josep Vidal-Alaball, Maria Isabel Del Cura-Gonzalez, Ricardo Rodriguez Barrientos, Rafel Ramos-Blanes, Alberto Alum Bou, Elsa Mondou, Mireia Torres, Neus Campins, Ana Sanz, Yonggiang Tang, Miquel Angel Rodriguez-Arias, Quique Bassat, Bonaventura Clotet, Oriol Mitja

Summary: This study assessed the safety and efficacy of subcutaneous anti-COVID-19 hyperimmune immunoglobulin 20% (C19-IG20%) in preventing the development of symptomatic COVID-19 in asymptomatic individuals with SARS-CoV-2 infection. The results showed that C19-IG20% did not prevent asymptomatic individuals from developing symptomatic COVID-19.

ECLINICALMEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

Potential for Maternally Administered Vaccine for Infant Group B Streptococcus

S. A. Madhi, A. S. Anderson, J. Absalon, D. Radley, R. Simon, B. Jongihlati, R. Strehlau, A. M. van Niekerk, A. Izu, N. Naidoo, G. Kwatra, Y. Ramsamy, M. Said, S. Jones, L. Jose, L. Fairlie, S. L. Barnabas, R. Newton, S. Munson, Z. Jefferies, D. Pavliakova, N. C. Silmon de Monerri, E. Gomme, J. L. Perez, D. A. Scott, W. C. Gruber, K. U. Jansen

Summary: This study evaluated the safety and immunogenicity of a hexavalent vaccine in pregnant women and found that it reduced the risk of group B streptococcal disease in newborns. The study also identified specific antibody concentrations associated with a reduced risk of disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Endothelial transcriptomic analysis identifies biomarkers of severe and cerebral malaria

Claudia Gomes, Rosauro Varo, Miquel Duran-Frigola, Antonio Sitoe, Rubio Bila, Sonia Machevo, Alfredo Mayor, Quique Bassat, Ana Rodriguez

Summary: Malaria can progress from an uncomplicated infection to a life-threatening severe disease. Early symptoms are often nonspecific, making it difficult to identify patients at high risk. By analyzing the transcriptomic response of human brain microvascular endothelial cells to Plasmodium falciparum-infected erythrocytes, several biomarkers have been identified to distinguish uncomplicated from severe malaria, as well as to differentiate children with cerebral malaria within the severe malaria group.

JCI INSIGHT (2023)

添加到收藏夹

Review Medicine, General & Internal

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data

Shuo Feng, Julie McLellan, Nicola Pidduck, Nia Roberts, Julian P. T. Higgins, Yoon Choi, Alane Izu, Mark Jit, Shabir A. Madhi, Kim Mulholland, Andrew J. Pollard, Beth Temple, Merryn Voysey

Summary: This systematic review and meta-analysis found differences in immunogenicity and efficacy between pneumococcal conjugate vaccines (PCV13 and PCV10). PCV13 demonstrated higher immunogenicity for specific serotypes and lower risk of seroinfection compared to PCV10. Additionally, a higher antibody response after vaccination was associated with a decreased risk of subsequent infection.

ECLINICALMEDICINE (2023)

添加到收藏夹

Article Pediatrics

SARS-CoV-2 transmission in teenagers and young adults in Futbol Club Barcelona's Multidisciplinary Sports Training Academy

Maria Hernandez-Garcia, Quique Bassat, Victoria Fumado, Gil Rodas, Ramon Pi, Maite Miranda-Garcia, Monica Girona-Alarcon, Marti Catala, Sergio Alonso, Enrique Alvarez-Lacalle, Daniel Lopez, Maria Mele-Casas, Gemma Pons-Tomas, Mariona F. de Sevilla, Elisenda Bonet-Carne, Claudia Fortuny, Aleix Garcia-Miquel, Cristina Jou, Cristina Adroher, Joana Claverol, Marta Cubells, Anna Codina, Daniel Cuadras, Eduard Gratacos, Pedro Brotons, Carmen Munoz-Almagro, Clara Prats, Juan Jose Garcia-Garcia, Iolanda Jordan

Summary: Studies show that engaging in physical activities in stable sports teams is not associated with an increased risk of SARS-CoV-2 transmission, whereas indoor sports and closed living settings can increase the risk. Fulfillment of preventive measures is essential.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

添加到收藏夹

Letter Immunology

Reply to Zayet et al

Nuria Balanza, Caroline K. Francis, Valerie M. Crowley, Andrea M. Weckman, Kathleen Zhong, Barbara Baro, Rosauro Varo, Quique Bassat, Kevin C. Kain

JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.